Diego A. Díaz García/X
Jul 15, 2025, 02:14
Diego A. Díaz García: Survival of Patients With Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020
Diego A. Díaz García, Medical Oncologist / CEO / Founder at CánCare – Advanced Specialty in Oncology, shared a post on X
“Survival of pts with Lung Adenocarcinoma diagnosed in 2000, 2010, and 2020. Median OS in lung adenocarcinoma more than doubled in 20 years (8.5 → 20.7 months) in non-academic public hospitals in France.
Targeted therapy and immunotherapy significantly improved outcomes, even outside academic centers. “
You can read the article here
You can also read about Immunotherapy for Lung Cancer
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 4, 2025, 14:50
Aug 4, 2025, 14:43
Aug 4, 2025, 14:39
Aug 4, 2025, 14:38
Aug 4, 2025, 14:30
Aug 4, 2025, 13:47
Aug 4, 2025, 13:24
Aug 4, 2025, 13:01